Influence of growth factors and cytokines on angiogenic function of endothelial progenitor cells: A review of in vitro human studies

Growth Factors

Volumn 32, Issue 3-4, 2014, Pages 83-116

  Peplow, Philip V ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Angiogenic potential; Cytokine; Endothelial progenitor cell; Growth factor

Indexed keywords

ANGIOGENIC FACTOR; ANTIBIOTIC AGENT; COLLAGEN GEL; CYTOKINE; FIBROBLAST GROWTH FACTOR 2; GROWTH FACTOR; INTERLEUKIN 1BETA; INTERLEUKIN 3; MATRIGEL; NERVE GROWTH FACTOR; PLACENTAL GROWTH FACTOR; RECOMBINANT GROWTH FACTOR; STEM CELL FACTOR; STROMAL CELL DERIVED FACTOR 1; THROMBOPOIETIN; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; SIGNAL PEPTIDE;

ACIDITY; ANGIOGENESIS; APOPTOSIS; ARTICLE; BIOLOGICAL ACTIVITY; CELL ASSAY; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; CELL STRUCTURE; CELL SURVIVAL; CELL TYPE; CHEMOTAXIS; ENDOTHELIAL PROGENITOR CELL; HUMAN; HUMAN CELL CULTURE; IN VITRO STUDY; MEDLINE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SERUM; STARVATION; SYSTEMATIC REVIEW; CELL MOTION; CYTOLOGY; GENETICS; METABOLISM; PHYSIOLOGY;

CELL MOVEMENT; CELL PROLIFERATION; CYTOKINES; ENDOTHELIAL PROGENITOR CELLS; HUMANS; IN VITRO TECHNIQUES; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; NEOVASCULARIZATION, PHYSIOLOGIC;

EID: 84905041837     PISSN: 08977194     EISSN: 10292292     Source Type: Journal    
DOI: 10.3109/08977194.2014.904300     Document Type: Article

References (77)

1. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, et al. 1997. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275: 964-967.
2. Assmus B, Schachinger V, Teupe C, Briutten M, Lahmann R, Döbert N, Grünwald F, et al. 2002. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCAREAMI). Circulation 106: 3009-3017.
3. Chen TG, Zhong ZY, Sun GF, Zhou YX, Zhao Y. 2011. Effects of tumour necrosis factor-alpha on activity and nitric oxide synthase of endothelial progenitor cells from peripheral blood. Cell Prolif 64: 352-359.
4. Chiche J, Brahimi-Horn MC, Pouyssegur J. 2010. Tumour hypoxia induces a metabolic shift causing acidosis: A common feature in cancer. J Cell Moll Med 14: 771-794.
5. Chung CH, Chang CF, Chen SS, Wang HH, Yen JY, Hsiao CJ, Wu NL, et al. 2013. Butein inhibits angiogenesis of human endothelial progenitor cells via the translation dependent signaling pathway. Evid Based Complement Alternat Med 2013: 943187.
6. CuccuiniW, Poitevin S, Poitevin G, Dignat-George F, Cornillet-Lefebvre P, Sabatier F, Nguyen P. 2010. Tissue factor up-regulation in proinflammatory conditions confers thrombin generation capacity to endothelial colony-forming cells without influencing non-coagulant properties in vitro. J Thromb Haemost 8: 2042-2052.
7. D'Atri LP, Etulain J, Romaniuk MA, Torres O, Negrotto S, Schattner M. 2011. The low viability of human CD34+ cells under acidic conditions is improved by exposure to thrombopoietin, stem cell factor, interleukin-3, or increased cyclic adenosine monophosphate levels. Transfusion 51: 1784-1795.
8. Diehl KJ, Well BP, Westby CM, MacEneaney OJ, Kushner EJ, Greiner JJ, DeSouza CA. 2012. Effects of endothelin-1 on endothelial progenitor cell function. Clin Chem Lab Med 50: 1121-1124.
9. Dimmeler S, Zeiher AM. 2004. Vascular repair by circulating endothelial progenitor cells: The missing link in atherosclerosis? J Mol Med 82: 671-677.
10. Eggermann J, Kliche S, Jarmy G, Hoffmann K, Mayr-Beyrle U, Debatin KM, Waltenberger J, Beltinger C. 2003. Endothelial progenitor cell culture and differentiation in vitro: A methodological comparison using human umbilical cord blood. Cardiovasc Res 58: 478-486.
11. Eguchi M, Masuda H, Kwon S, Shirakura K, Shizuno T, Ito R, Kobori M, Asahara T. 2008. Lesion-targeted thrombopoietin potentiates vasculogenesis by enhancing motility and enlivenment of transplanted endothelial progenitor cells via activation of Akt/mTOR/p70S6 kinase signaling pathway. J Mol Cell Cardiol 45: 661-669.
12. Evrard SM, d'Audigier C, Mauge L, Israel-Biet D, Guerin CL, Bieche I, Kovacic JC, et al. 2012. The profibrotic cytokine transforming growth factor-b1 increases endothelial progenitor cell angiogenic properties. Thromb Haemostr 190: 670-679.
13. Fiorito C, Rienzo M, Crimi E, Rossiello R, Balestrieri ML, Casamassimi A, Muto F, et al. 2008. Antioxidants increase number of progenitor endothelial cells through multiple gene expression pathways. Free Radic Res 42: 754-762.
14. Goretti E, Rolland-Turner M, Leonard F, Zhang L, Wagner DR, Devaux Y. 2013. MicroRNA-16 affects key functions of human endothelial progenitor cells. J Leukoc Biol 93: 645-655.
15. He T, Katusic ZS. 2012. Brain-derived neurotrophic factor increases expression of MnSOD in human circulating angiogenic cells. Microvasc Res 83: 366-371.
16. Henrich D, Seebach C, Wilhelm K, Marzi I. 2007. High dosage of simvastatin reduces TNF-a-induced apoptosis of endothelial progenitor cells but fails to prevent apoptosis induced by IL-1b in vitro. J Surg Res 142: 13-19.
17. Hristov M, Weber C. 2004. Endothelial progenitor cells: Pathophysiology, and possible clinical relevance. J Cell Mol Med 8: 498-508.
18. Huang PS, Chen YH, Tsai HY, Chen JS, Wu TC, Lin FY, Sata M, et al. 2010. Intake of red wine increases the number and functional capacity of circulating endothelial progenitor cells by enhancing nitric oxide bioavailability. Arterioscler Thromb Vasc Biol 30: 869-877.
19. Imanishi T, Hano T, Sawamura T, Nishio I. 2004. Oxidized low-density lipoprotein induces endothelial progenitor cell senescence, leading to cellular dysfunction. Clin Exp Pharmacol Physiol 31: 407-413.
20. Ishizawa K, Kubo H, Yamada M, Kobayashi S, Suzsuki T, Mizuno S, Nakamura T, Sasaki H. 2004. Hepatocyte growth factor induces angiogenesis in injured lungs through mobilizing endothelial progenitor cells. Biochem Biophys Res Commun 324: 276-280.
21. Jadhao CS, Bhatwadekar AD, Jiang Y, Boulton ME, Steinle JJ, Grant MB. 2012. Nerve growth factor promotes endothelial progenitor cellmediated angiogenic responses. Invest Ophthalmol Vis Sci 53: 2030-2037.
22. Jeon O, Hwang KC, Yoo KJ, Kim BS. 2006. Combined sustained delivery of basic fibroblast growth factor and administration of granulocyte colony-stimulating factor: Synergistic effect on angiogenesis in mouse ischemic limbs. J Endovasc Ther 13: 175-181.
23. Jiang S, Walker L, Afentoulis M, Anderson DA, Jauron-Mills L, Corless CL, Fleming WH. 2004. Transplanted human bone marrow contributes to vascular endothelium. Proc Natl Acad Sci USA 101: 16891-16896.
24. Jin F, Hagemann N, Schafer ST, Brockmeier U, Zechariah A, Hermann DM. 2013. SDF-1 restores angiogenesis synergistically with VEGF upon LDL exposure despite CXCR4 internalization and degradation. Cardiovasc Res 100: 481-491.
25. Jones CP, Pritchford SC, Lloyd CM, Rankin SM. 2009. CXCR2 mediates the recruitment of endothelial progenitor cells during allergic airways remodeling. Stem Cells 27: 3074-3081.
26. Jones SA. 2005. Directing transition from innate to acquired immunity: Defining a role for IL-6. J Immunol 175: 3463-3468.
27. Kalka C, Masuda H, Takahashi T, Kalka-Moll WM, Silver M, Kearney M, Li T, et al. 2000. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci USA 97: 3422-3427.
28. Kanzler I, Tuchscheerer N, Steffens G, Simsekyilmaz S, Konschalla S, Kroh A, Simons D, et al. 2013. Differential roles of angiogenic chemokines in endothelial progenitor cell-induced angiogenesis. Basic Res Cardiol 108: 310-323.
29. Kawamoto A, Gwon HC, Iwaguro H, Yamaguchi JI, Uchida S, Masuda H, Silver M, et al. 2001. Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation 103: 634-637.
30. Korff T, Augustin HG. 1998. Integration of endothelial cells in multicellular spheroids prevents apoptosis and induces differentiation. J Cell Biol 143: 1341-1352.
31. Kumar S, Kasseckert S, Kostin S, Abdallah Y, Schafer C, Kaminski A, Reusch HP, et al. 2007. Ischemic acidosis causes apoptosis in coronary endothelial cells through activation of caspase-12. Cardiovasc Res 73: 172-180.
32. Li B, Sharpe EE, Maupin AB, Teleron AA, Pyle AL, Carmeliet P, Young PP. 2006. VEGF and PlGF promote adult vasculogenesis by enhancing EPC recruitment and vessel formation at the site of tumor neovascularization. FASEB J 20: 1495-1497.
33. Li X, Song Y, Wang D, Fu C, Zhu Z, Han Y, Li C, et al. 2012. LIF maintains progenitor phenotype of endothelial progenitor cells via Kruppel-like factor 4. Microvasc Res 84: 270-277.
34. Ma LX, Huang YH, Cheng LM, Lei J, Wang QR. 2007. Inducing effects of macrophage stimulating protein on the expansion of early hematopoietic progenitor cells in liquid culture. Chin Med J 120: 1192-1197.
35. Mirshahi F, Pourtau J, Li H, Muraine M, Trochon V, Legrand E, Vannier J, et al. 2000. SDF-1 activity on microvascular endothelial cells: Consequences on angiogenesis in in vitro and in vivo models. Thromb Res 99: 587-594.
36. Nakamura S, Kimura M, Goto C, Noma K, Yoshizumi M, Chayama K, Kihara Y, Higashi Y. 2009. Cigarette smoking abolishes ischemic preconditioning-induced augmentation of endothelium-dependent vasodilation. Hypertension 53: 674-681.
37. Netelenbos T, Zuijderduijn S, van den Born J, Kessler FL, Zweegman S, Huijgens PC, Dräger AM. 2002. Proteoglycans guide SDF-1-induced migration of hematopoietic progenitor cells. J Leukoc Biol 72: 353-362.
38. O E, Ahn HY, Kim, HK, You JC, Shin JC, Joe YA. 2011. The Rho kinase inhibitor fasudil augments the number of functional endothelial progenitor cells in ex vivo cultures. Int J Mol Med 28: 357-363.
39. Peichev M, Nalyer AJ, Pereira D, Zhu Z, Lane WJ, Williams M, Oz MC, et al. 2000. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 95: 952-958.
40. Peled A, Petit I, Kollet O, Magid M, Ponomaryov T, Byk T, Nagler A, et al. 1999. Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science 283: 845-848
41. . Raida M, Heymann AC, Gunther C, Niederwieser D. 2006. Role of bone morphogenetic protein 2 in the crosstalk between endothelial progenitor cells and mesenchymal stem cells. Int J Mol Med 18: 735-739.
42. Rehman J, Li J, Orschell CM, March KL. 2003. Peripheral blood ''endothelial progenitor cells'' are derived from monocyte/macrophage and secrete angiogenic growth factors. Circulation 107: 1164-1169.
43. Rolland-Turner M, Goretti E, Bousquenaud M, Leonard F, Nicolas C, Zhang L, Maskali F, et al. 2013. Adenosine stimulates the migration of human endothelial progenitor cells: Role of CXCR4 and microRNA-150. PLoS One 8: e54135.
44. Rosell A Arai K, Lok J, He T, Guo S, Navarro M, Montaner J, et al. 2009. Interleukin-1beta augments angiogenic responses of murine endothelial progenitor cells in vitro. J Cerebral Blood Flow Metab 29: 933-943.
45. Shen L, Gao Y, Qian J, Wu Y, Zhou M, Sun A, Zou Y, Ge J. 2012. The role of SDF-1a/Rac pathway in the regulation of endothelial progenitor cell polarity: Homing and expression of Rac1, Rac2 during endothelial repair. Mol Cell Biochem 365: 1-7.
46. Shintani S, Kusano K, Ii M, Iwakura A, Heyd L, Curry C, Wecker A, et al. 2006. Synergistic effect of combined intramyocardial CD34 cells and VEGF2 gene therapy after MI. Nat Clin Pract Cardiovasc Med 3: S123-S128.
47. Shmilovich H, Ben-Shoshan J, Tal R, Afek A, Barshack I, Maysel-Auslander S, Harats D, et al. 2009. B-type natriuretic peptide enhances vasculogenesis by promoting number and functional properties of early endothelial progenitor cells. Tissue Eng Part a 15: 2741-2749.
48. Shweiki D, Ahuva I, Soffer D, Keshet E. 1992. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359: 843-845.
49. Simons D, Grieb G, Hristov M, Pallua N, Weber C, Bernhagen J, Steffens G. 2011. Hypoxia-induced endothelial secretion of macrophage migration inhibitory factor and role in endothelial progenitor cell recruitment. J Cell Mol Med 15: 668-678.
50. Smadja DM, Bieche I, Helley D, Laurendeau I, Simonin G, Muller L, Aiach M, Gaussem P. 2007. Increased VEGFR2 expression during human late endothelial progenitor cells expansion enhances in vitro angiogenesis with up-regulation of integrin a6. J Cell Mol Med 11: 1149-1161.
51. Song MB, Yu XJ, Zhu GX, Chen JF, Zhao G, Huang L. 2009. Transfection of HGF gene enhances endothelial progenitor cell (EPC) function and improves EPC transplant efficiency for balloon-induced arterial injury in hypercholesterolemic rats. Vascul Pharmacol 51: 205-213.
52. Strauer BE, Brehm M, Zeus T, Kostering M, Hernandez A, Sorg RV, Kögler G, Wernet P. 2002. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 106: 1913-1918.
53. Sufen G, Xianghong Y, Yongxia C, Qian P. 2011. bFGF and PDGF-BB have a synergistic effect on the proliferation, migration and VEGF release of endothelial progenitor cells. Cell Biol Int 35: 545-551.
54. Suh W, Kim KL, Choi JH, Lee YS, Lee JY, Kim JM, Jang HS, et al. 2004. C-reactive protein impairs angiogenic functions and decreases the secretion of arteriogenic chemo-cytokines in human endothelial progenitor cells. Biochem Biophys Res Commun 321: 65-71.
55. Szmitko PE, Fedak PW, Weisel RD, Stewart DJ, Kutryk MJ, Verma S. 2003. Endothelial progenitor cells: New hope for a broken heart. Circulation 107: 3093-3100.
56. Tan Y, Shao H, Eton D, Yang Z, Alonso-Diaz L, Zhang H, Schulick A, et al. 2007. Stromal cell-derived factor-1 enhances pro-angiogenic effect of granulocyte-colony stimulating factor. Cardiovascular Res 73: 823-832.
57. Tateishi-Yuyama E, Matsubara H, Murohara T, Uichi I, Shintani S, Masaki H, Amano K, et al. 2002. Therapeutic angiogenesis of patients with limb ischaemia by autologous transplantation of bone-marrow cells: A pilot study and a randomised controlled trial. Lancet 360: 427-435.
58. Teleron AA, Carlson B, Young PP. 2005. Blood donor white blood cell reduction filters as a source of human peripheral blood-derived endothelial progenitor cells. Transfusion 45: 21-25.
59. Tran CA. 2006. Inhibition of preadipocyte differentiation by TNF-alpha and interferon (alpha, beta, and gamma): Global gene expression analysis. Ann Arbor, MI: Tufts University, ProQuest, UMI Dissertations Publishing.
60. Trevani AS, Andonegui G, Giordano M, Lopez DH, Gamberale R, Minucci F, Geffner JR. 1999. Extracellular acidification induces human neutrophil activation. J Immunol 162: 4849-4857.
61. Van Craenenbroeck EM, Denollet J, Paelinck BP, Beckers P, Possemiers N, Hoymans VY, Vrints CJ, Conraads VM. 2009. Circulating CD34/ KDR endothelial progenitor cells are reduced in chronic heart failure patients as a function of Type D personality. Clin Sci 117: 165-172.
62. Van Epps DE, Bender J, Lee W, Schilling M, Smith A, Smith S, Unverzagt K, et al. 1994. Harvesting, characterization, and culture of CD34+ cells from human bone marrow, peripheral blood and cord blood. Blood Cells 20: 411-423.
63. Verma S, Kuliszewski MA, Li SH, Szmitko PE, Zucco L, Wang CH, Badiwala MV, et al. 2004. C-reactive protein attenuates endothelial progenitor cell survival, differentiation, and function. Circulation 109: 2058-2067.
64. Wu Y, Dai J, Schmuckler NG, Bakdash N, Yoder MC, Overall CM, Colman RW. 2010. Cleaved high molecular weight kininogen inhibits tube formation of endothelial progenitor cells via suppression of matrix metalloproteinase 2. J Thromb Haemost 8: 185-193.
65. Xie XY, Mo ZH, Chen K, He HH, Xie YH. 2011. Glucagon-like peptide- 1 improves proliferation and differentiation of endothelial progenitor cells via upregulating VEGF generation. Med Sci Monit 17: BR35-BR41.
66. Yamaguchi J, Kusano KF, Masuo O, Kawamoto A, Silver M, Murasawa S, Bosch-Marce M, et al. 2003. Stromal cell derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation 107: 1322-1328.
67. Yang L, Yang XC, Yang JK, Guo YH, Yi FF, Fan Q, Liu XL. 2008. Cyclosporin A suppresses proliferation of endothelial progenitor cells: Involvement of nitric oxide synthase inhibition. Intern Med 47: 1457-1464.
68. Yang L, Guo XG, Du CQ, Yang JX, Jiang DM, Li B, Zhou WJ, Zhang FR. 2012. Interleukin-1 beta increases activity of human endothelial progenitor cells: Involvement of PI3K-Akt signaling pathway. Inflammation 35: 1242-1250.
69. Yoder MC. 2013. Early and late endothelial progenitor cells are miRtually exclusive. J Leuk Biol 93: 639-641.
70. Yoder MC, Mead LE, Prater D, Kier TR, Mroueh KN, Li F, Krasich R, et al. 2007. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 109: 1801-1809.
71. Yu JX, Huang XF, Lv WM, Ye CS, Peng XZ, Zhang H, Xiao LB, Wang SM. 2009. Combination of stromal- derived factor-1alpha and vascular endothelial growth factor gene-modified endothelial progenitor cells is more effective for ischemic neovascularization. Vasc Surg 50: 608-616.
72. Yu M, Liu Q, Yi K, Wu L, Tan X. 2011. Effects of osteopontin on functional activity of late endothelial progenitor cells. J Cell Biochem 112: 1730-1736.
73. Zemani F, Benisvy D, Galy FI, Lokajczyk A, Colliec-Jouault S, Uzan G, Fischer AM, Boisson-Vidal C. 2005. Low-molecular- weight fucoidan enhances the proangiogenic phenotype of endothelial progenitor cells. Biochem Pharmacol 70: 1167-1175.
74. Zemani F, Silvestre JS, Fauvel-Lafeve F, Bruel A, Vilar J, Bieche I, Laurendeau I, et al. 2008. Ex vivo priming of endothelial progenitor cells with SDF-1 before transplantation could increase their proangiogenic potential. Arterioscler Thromb Vasc Biol 28: 644-650.
75. Zhang Y, Ingram DA, Murphy MP, Saadatzadeh MR, Mead LE, Prater DN, Rehman J. 2009. Release of proinflammatory mediators and expression of proinflammatory adhesion molecules by endothelial progenitor cells. Am J Physiol Heart Circ Physiol 296: H1675-H1682.
76. Zheng H, Dai T, Zhou B, Zhu J, Huang H, Wang M, Fu G. 2008. SDF-1a decreases endothelial progenitor cells apoptosis under serum deprivation by PI3K/Akt/eNOS pathway. Atherosclerosis 201: 36-42.
77. Zheng H, Fu G, Dai T, Huang H. 2007. Migration of endothelial progenitor cells mediated by stromal cell-derived factor-1a/CXCR4 via PI3K/Akt/eNOS signal transduction pathway. J Cardiovasc Pharmacol 50: 274-280.